Key result
Mitral stenosis was associated with a significantly longer pulmonary pulse transit time compared to controls (0.21 vs 0.15, P < .001), with longer times observed in symptomatic patients.
Why the study?
Pulmonary pulse transit time is known to be shorter in precapillary pulmonary hypertension, but its behavior in postcapillary pulmonary hypertension caused by mitral stenosis and its relationship with symptoms were uninvestigated.
Is prolonged pulmonary pulse transit time associated with symptoms in patients with significant mitral stenosis and sinus rhythm?
Observational (n=101)
Is prolonged pulmonary pulse transit time associated with symptoms in patients with significant mitral stenosis and sinus rhythm?
Pulmonary pulse transit time is prolonged in patients with mitral stenosis and correlates with symptom severity and echocardiographic markers of pulmonary hemodynamics.
Answers are grounded in this paper and cite their sources.
May aid symptom stratification in mitral stenosis; leaves open pPTT utility in postcapillary pulmonary hypertension pending validation.
INTRODUCTION: Pulmonary pulse transit time (pPTT) is a novel noninvasive echocardiographic measure to assess pulmonary arterial hemodynamics. It has been shown to be shorter in precapillary pulmonary hypertension (PHT). Mitral stenosis (MS) is one of the causes of postcapillary PHT. We aimed to investigate pPTT in patients with MS and its relationship with symptoms. METHODS: We included 51 patients with MS (25 were asymptomatic, NYHA I, and 26 were symptomatic, NHYA II or III), and 50 controls, and evaluated their demographic characteristics and echocardiographic variables, including pPTT. RESULTS: Baseline characteristics, including age, sex, body mass index, and cardiovascular risk factors, were similar between the MS and the control group. The pPTT was longer in the MS group than in the control group (0.21 ± 0.08 vs 0.15 ± 0.05, P < .001). Patients with symptomatic MS had longer pPTT than asymptomatic patients (P = .005). The pPTT was positively correlated with left atrial volume index and systolic pulmonary artery pressure, and negatively with tricuspid annular plane systolic excursion (r = .432; P < .001, r = .319; P = .001, r = -.293; and P = .003, respectively). CONCLUSION: The measurement of pPTT appears clinically relevant in patients with PHT. Further studies evaluating whether it is useful in distinguishing precapillary from postcapillary PHT are required.
No takes yet. Share an insight, caveat, or question.
Gürbüz et al. (2019) conducted an observational in Mitral stenosis (n=101). Mitral stenosis vs. Controls was evaluated on Pulmonary pulse transit time (pPTT) (p=<.001). Mitral stenosis was associated with a significantly longer pulmonary pulse transit time compared to controls (0.21 vs 0.15, P < .001), with longer times observed in symptomatic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: